fig4

New insights into acquired endocrine resistance of breast cancer

Figure 4. Regulation of nuclear factor κB (NF-κB) DNA-binding activity by other transcription factors in acquired resistant breast cancer cells. E2/estrogen receptor α (ERα) activates endoplasmic reticulum stress and subsequently increases NF-κB DNA-binding activity. However, lipid metabolism-associated transcription factors CCAAT/enhancer binding protein β (C/EBP β) and peroxisome proliferator-activated receptor γ (PPARγ) and inflammation modulator GR all suppress the DNA-binding activity of NF-κB, thereby inhibition of E2-induced apoptosis in long term estrogen deprivation breast cancer cells

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/